Home › Funds › BANTAMAC CAPITAL, LLC › AMGN

BANTAMAC CAPITAL, LLC position in AMGN

AMGEN INC · Health Care

BANTAMAC CAPITAL, LLC reported holding 800 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$337K, representing 0.88% of its reported portfolio and ranking #13 among its reported holdings. BANTAMAC CAPITAL, LLC has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)800 sh
Reported value held$337.21K
Portfolio Weight0.88%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BANTAMAC CAPITAL, LLC's AMGN position evolved

BANTAMAC CAPITAL, LLC first disclosed a stake in AMGN in Q3 2023 at 2,384 shares (US$641K). The position peaked in Q3 2024 at 2,277 shares, worth US$734K. Across 13 filings, BANTAMAC CAPITAL, LLC increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 800 shares valued at US$337K — a reduction of -1,100 shares quarter over quarter.. Notable position changes include a 58% trim in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.38K $640.72K New
Q4 2023 2.45K $706.80K Add
Q1 2024 2.42K $688.05K Reduce
Q2 2024 2.29K $716.13K Reduce
Q3 2024 2.28K $733.67K Reduce
Q4 2024 2.28K $593.48K Hold
Q1 2025 2.23K $695.38K Reduce
Q2 2025 2.20K $614.26K Reduce
Q3 2025 2.10K $592.62K Reduce
Q4 2025 2.00K $654.62K Reduce
Q1 2026 1.91K $672.03K Reduce
Q2 2026 1.90K $688.03K Reduce
Q3 2026 800 $337.21K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 30 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), VANGUARD CAPITAL MANAGEMENT LLC (US$14.92B), STATE STREET CORP (US$13.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has BANTAMAC CAPITAL, LLC held AMGN?

BANTAMAC CAPITAL, LLC has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BANTAMAC CAPITAL, LLC's current position in AMGN?

As of Q3 2026, BANTAMAC CAPITAL, LLC holds 800 shares of AMGN (AMGEN INC), valued at $337.21K, representing 0.88% of its reported portfolio and ranking #13.

Has BANTAMAC CAPITAL, LLC been buying or selling AMGN?

In the latest 13F filing (Q3 2026), BANTAMAC CAPITAL, LLC reduced its position in AMGN. The position peaked in Q3 2024 at 2.28K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.